Ultragenyx Pharmaceutical reported $-2.19 in EPS Earnings Per Share for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acadia Pharmaceuticals ACAD:US $ 0K 0K
Agios Pharmaceuticals AGIO:US -1.74 0
Alnylam Pharmaceuticals ALNY:US $ -2 0.16
Aptinyx Inc APTX:US -0.29 0
Biocryst Pharmaceuticals BCRX:US -0.4 0.3
Biomarin Pharmaceutical BMRN:US $ 0.18 0.5
Bluebird Bio BLUE:US $ -1.66 0.48
Epizyme EPZM:US -0.38 0.11
Esperion Therapeutics ESPR:US -0.93 0.84
Insmed INSM:US -0.8 0.15
IONIS PHARMACEUT IONS:US $ -0.46 1.87
Karyopharm Therapeutics KPTI:US -0.53 0.99
Kyowa Hakko Kirin 4151:JP Y 29.85 6.33
Macrogenics MGNX:US -1.08 0.13
Mirati Therapeutics MRTX:US -3.4 0.32
Moderna Inc MRNA:US 8.58 2.71
Neurocrine Biosciences NBIX:US $ 0.3 0.38
Ptc Therapeutics PTCT:US $ -1.78 0.25
Puma Biotechnology PBYI:US $ -0.08 0.18
Regeneron Pharmaceuticals REGN:US $ 8.93 12.39
Sarepta Therapeutics SRPT:US -1.2 0.22
Ultragenyx Pharmaceutical RARE:US $ -2.19 0.4
Vertex Pharmaceuticals VRTX:US $ 3.52 0.15
Vital Therapies VTL:US $ -0.74 0.02
Xoma XOMA:US -0.32 1.99